Estimating the Cost Impact of Switching from a Vial to a Pre-Filled Syringe Mode of Administration for the DTaA-IPV-Hib ‘5-In-1’ Vaccine in Infants
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.135
https://www.valueinhealthjournal.com/article/S1098-3015(13)02040-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
124
First Page :
A345
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02040-8&doi=10.1016/j.jval.2013.08.135